CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, inflammation, cardiovascular, and metabolic disease Drug Discovery.
Our premier Translational Platforms for cancer, inflammation, and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products.
CrownBio’s Life Science division specializes in in vivo and in vitro reagents to support and accelerate our partners’ preclinical research, drug development, and validation efforts. Placing cancer research as a top priority, our continuously expanding and wide collection of products were developed specifically for your preclinical oncology studies.
We are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.